Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Эффективность повторных эндоваскулярных вмешательств при развитии рестеноза различных типов стентов
Эффективность повторных эндоваскулярных вмешательств при развитии рестеноза различных типов стентов
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Cremers B, Clever Y, Schaffner S et al. Treatment of coronary in-stent restenosis with a novel paclitaxel urea coated balloon. Minerva Cardioangiol 2010; 58 (5): 583–8.
2. Vaknin-Assa H, Assali A, Lev E et al. Characterization and clinical outcomes of drug-eluting in-stent restenosis. Isr Med Assoc J 2010; 12 (5): 273–6.
3. Trial of invasive versus medical therapy in elderly patients. TIME. Lancet 2001; 358: 951–7.
4. Pfisterer M, Buser P. Outcome of elderly patients with chronic symptomatic coronary artery disease. One-year results from TIME trial. JAMA 2003; 289: 1117–23.
5. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularization Investigation). CABRI trial Participants. Lancet 1995; 346: 1179–84.
6. Qian F, Hannan EL, Glance LG et al. Coronary stent use in New York State in the drug-eluting stent era. J Eval Clin Pract 2011. doi: 10.1111/j.1365–2753.2011.01699.x
7. Weisz et al. Two-year results ot the SIRIUS trial. J Am Coll Cardiol 2006; 47: 1350–3.
8. Mehilii et al. ISAR-SMART 3 trial. Eur Heart J 2006; 27: 260–6.
9. Kelbaek et al. J Am Coll Cardiol 2006; 47: 449–55.
10. Alfonso F, Zueco J. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol 2003; 42; 796–805.
11. Alfonso F, Auge JM. Long-term results of the Restenosis Intrastent (RIBS) study. J Am Coll Cardiol 2005; 46: 756–60.
2. Vaknin-Assa H, Assali A, Lev E et al. Characterization and clinical outcomes of drug-eluting in-stent restenosis. Isr Med Assoc J 2010; 12 (5): 273–6.
3. Trial of invasive versus medical therapy in elderly patients. TIME. Lancet 2001; 358: 951–7.
4. Pfisterer M, Buser P. Outcome of elderly patients with chronic symptomatic coronary artery disease. One-year results from TIME trial. JAMA 2003; 289: 1117–23.
5. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularization Investigation). CABRI trial Participants. Lancet 1995; 346: 1179–84.
6. Qian F, Hannan EL, Glance LG et al. Coronary stent use in New York State in the drug-eluting stent era. J Eval Clin Pract 2011. doi: 10.1111/j.1365–2753.2011.01699.x
7. Weisz et al. Two-year results ot the SIRIUS trial. J Am Coll Cardiol 2006; 47: 1350–3.
8. Mehilii et al. ISAR-SMART 3 trial. Eur Heart J 2006; 27: 260–6.
9. Kelbaek et al. J Am Coll Cardiol 2006; 47: 449–55.
10. Alfonso F, Zueco J. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol 2003; 42; 796–805.
11. Alfonso F, Auge JM. Long-term results of the Restenosis Intrastent (RIBS) study. J Am Coll Cardiol 2005; 46: 756–60.
Авторы
А.М.Герасимов, О.В.Черкавская, Ф.Т.Агеев, А.П.Савченко
ФГБУ Российский кардиологический научно-производственный комплекс Минздравсоцразвития РФ, Москва.
ФГБУ Российский кардиологический научно-производственный комплекс Минздравсоцразвития РФ, Москва.
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.